Therapeutic Effects of Aripiprazole in the 5xFAD Alzheimer’s Disease Mouse Model

Therapeutic Effects of Aripiprazole in the 5xFAD Alzheimer’s Disease Mouse Model

Global aging has led to growing health concerns posed by Alzheimer’s disease (AD), the most common type of dementia. Aripiprazole is an atypical FDA-approved anti-psychotic drug with potential against AD. To investigate its therapeutic effects on AD pathology, we administered aripiprazole to 5xFAD A...

Full description

Bibliographic Details
Main Authors: Ye Ji Jeong, Yeonghoon Son, Hye-Jin Park, Se Jong Oh, Jae Yong Choi, Young-Gyu Ko, Hae-June Lee
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
aripiprazole
Alzheimer’s disease mice
βA pathology
FDG-PET
therapeutic agent
Online Access:https://www.mdpi.com/1422-0067/22/17/9374

Internet

https://www.mdpi.com/1422-0067/22/17/9374

Similar Items